Table 1 Analysis of physical examination data among different subgroups
< 40 year-old group | ≥ 40 year-old group | |||||||
|---|---|---|---|---|---|---|---|---|
IgG negative | IgG positive | t/x2 | P | IgG negative | IgG positive | t/x2 | P | |
Gender | ||||||||
Woman (n/%) | 1064/30.18 | 2055/42.50 | 132.47 | < 0.001 | 3106/31.97 | 4442/43.47 | 280.73 | < 0.001 |
Man (n/%) | 2462/69.82 | 2780/57.50 | 6610/68.03 | 5773/56.53 | ||||
Distribution of BMI | ||||||||
< 18.5 kg/m2 (n/%) | 178/5.05 | 348/7.20 | 73.31 | < 0.001 | 106/1.1 | 150/1.47 | 25.64 | < 0.001 |
18.5–23.9 kg/m2 (n/%) | 1596/45.28 | 2525/52.22 | 3632/37.37 | 4115/40.28 | ||||
≥ 24.0 kg/m2 (n/%) | 1752/49.67 | 1962/40.58 | 5978/61.53 | 5950/58.25 | ||||
Central obesity (n/%) | 973/29.93 | 1069/23.65 | 38.55 | < 0.001 | 3611/40.34 | 3591/38.06 | 9.72 | 0.01 |
Dysarteriotony | 181/12.03 | 163/9.54 | 5.22 | 0.02 | 1061/25.89 | 822/24.71 | 1.34 | 0.25 |
SBP (mmHg) | 117.85 ± 15.52 | 115.88 ± 14.51 | 3.72 | < 0.001 | 124.73 ± 18.64 | 124.63 ± 18.47 | 0.24 | 0.81 |
DBP (mmHg) | 75.04 ± 11.86 | 72.42 ± 10.94 | 6.51 | < 0.001 | 79.02 ± 12.94 | 78.28 ± 12.59 | 2.48 | 0.01 |
Dyslipidemia (n/%) | 1751/49.66 | 2150/44.47 | 22.09 | < 0.001 | 5769/59.37 | 5624/55.06 | 37.95 | < 0.001 |
Hypertriglyceridemia (n/%) | 1376/39.02 | 1390/28.75 | 97.25 | < 0.001 | 4354/44.81 | 3882/38.01 | 95.24 | < 0.001 |
Hypercholesteremia (n/%) | 631/17.90 | 731/15.12 | 11.53 | < 0.001 | 2785/28.66 | 2723/26.66 | 10.03 | 0.01 |
High LDL-C (n/%) | 511/15.21 | 677/15.23 | 0.001 | 0.98 | 2391/24.78 | 2518/24.83 | 0.01 | 0.94 |
Low HDL-C (n/%) | 181/5.39 | 175/3.94 | 9.23 | 0.01 | 443/4.59 | 412/4.06 | 3.34 | 0.07 |
Distribution of FBG | ||||||||
< 6.1 mmol/L (n/%) | 3241/91.92 | 4597/95.08 | 69.31 | < 0.001 | 7902/81.33 | 8557/83.77 | 29.34 | < 0.001 |
6.1–6.9 mmol/L (n/%) | 181/5.13 | 158/3.27 | 1002/10.31 | 945/9.25 | ||||
≥ 7.0 mmol/L (n/%) | 104/2.95 | 80/1.65 | 812/8.36 | 713/6.98 | ||||
Uric acid (umol/L) | 364.05 ± 97.71 | 350.92 ± 98.28 | 6.05 | < 0.001 | 353.57 ± 93.16 | 339.95 ± 93.75 | 10.28 | < 0.001 |
Abnormal liver function (n/%) | 1345/38.24 | 1374/28.58 | 86.27 | < 0.001 | 3554/36.73 | 3151/30.92 | 74.86 | < 0.001 |
Albumin (g/L) | 46.98 ± 2.52 | 46.91 ± 2.55 | 1.39 | 0.17 | 45.52 ± 2.71 | 45.47 ± 2.73 | 1.34 | 0.18 |
Hemoglobin (g/L) | 148.88 ± 15.61 | 145.02 ± 16.06 | 10.84 | < 0.001 | 146.12 ± 15.55 | 142.98 ± 15.90 | 13.86 | < 0.001 |
Abnormal renal function (n/%) | 46/1.30 | 55/1.14 | 0.48 | 0.49 | 226/2.33 | 209/2.05 | 1.83 | 0.18 |
Fatty liver disease (n/%) | 1114/31.59 | 1178/24.36 | 53.56 | < 0.001 | 3826/39.38 | 3526/34.52 | 50.53 | < 0.001 |
Gallbladder polyp (n/%) | 274/7.77 | 328/6.78 | 2.97 | 0.09 | 928/9.55 | 901/8.82 | 3.19 | 0.07 |
Gallstone (n/%) | 75/2.13 | 114/2.36 | 0.49 | 0.48 | 396/4.08 | 432/4.23 | 0.29 | 0.59 |
Renal calculus (n/%) | 126/3.57 | 143/2.96 | 2.48 | 0.12 | 439/4.52 | 427/4.18 | 1.37 | 0.24 |
Abnormalbone mineral density (n/%) | 373/69.63 | 373/64.42 | 3.42 | 0.06 | 3202/76.49 | 3209/75.81 | 0.54 | 0.46 |
Osteopenia (n/%) | 297/55.0 | 285/49.22 | 3.74 | 0.05 | 1990/47.54 | 2016/47.63 | 0.01 | 0.94 |
Osteoporosis (n/%) | 79/14.63 | 88/15.20 | 0.07 | 0.79 | 1212/28.95 | 1193/28.18 | 0.61 | 0.43 |
Thyroid nodule (n/%) | 639/25.0 | 923/29.03 | 11.59 | 0.01 | 2849/39.67 | 3092/43.45 | 20.93 | < 0.001 |
Lung lesions (n/%) | 85/2.78 | 95/2.40 | 0.99 | 0.32 | 561/6.15 | 570/5.97 | 0.28 | 0.60 |
Gastric lesions (n/%) | 60/28.04 | 69/27.49 | 0.02 | 0.90 | 296/38.99 | 268/37.69 | 0.27 | 0.61 |
Intestinal lesions (n/%) | 8/18.61 | 7/15.91 | 0.11 | 0.74 | 52/27.08 | 42/25.15 | 0.17 | 0.68 |
Abnormal cervical liquid-based cytological test (n/%) | 2/0.32 | 16/1.40 | 4.77 | 0.06 | 14/0.76 | 19/0.71 | 0.04 | 0.85 |
Breast lesions (n/%) | 549/65.75 | 951/64.52 | 0.35 | 0.55 | 1323/60.99 | 1931/62.43 | 1.11 | 0.29 |
Abnormal gynecological ultrasonography (n/%) | 273/36.45 | 491/38.69 | 1.01 | 0.32 | 1190/55.63 | 1809/57.72 | 2.26 | 0.13 |
Prostatic lesion (n/%) | 76/6.11 | 59/5.01 | 1.40 | 0.24 | 1017/17.93 | 823/16.58 | 3.39 | 0.07 |